まとめ
繊維芽細胞は,組織プラズミノゲン活性化剤 (tPA) に結合し,内部化する. 線維芽細胞によるこの酵素連鎖は表面受容体を含み,tPAの分解につながり,プロテアセンキシン媒介結合とは異なる.
科学分野:
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
- 酵素学 酵素学とは
背景:
- 組織プラズミノゲン活性化剤 (tPA) は,線維分解に不可欠です.
- 細胞とのtPAの相互作用を理解することは,その治療的応用に不可欠です.
- 繊維芽細胞は,組織リモデリングとマトリックスダイナミクスに関与する一般的な細胞です.
研究 の 目的:
- 繊維芽細胞が組織プラズミノゲン活性化剤 (tPA) と相互作用し,内部化するメカニズムを調査する.
- フィブロブラストによるtPA結合に関与する結合運動学と細胞成分を特徴づける.
- この相互作用を,他の既知のtPA結合現象と区別するために.
主な方法:
- 生体およびエタノールに固定された線維芽細胞をtPAを含む媒介でインキュベーションする.
- tPAの結合と結合の運動分析.
- 結合されたtPAの酵素活性測定.
- 結合コンポーネントを特定するための電泳分析.
- ヘパリンとトロンビンの結合に対する効果の調査.
主要な成果:
- 繊維芽細胞は,tPAを媒介から効率的に結合して除去します.
- 固定細胞への結合は均衡運動性を示し,最大吸収量は2.4単位/10^6細胞であった.
- 結合したtPAは酵素活性を維持し,プラズミノゲンを活性化し,カゼイノリシスを引き起こした.
- 電気フォレシスにより,tPAが40〜50 kDaの線維芽細胞成分に共振的に結合していることが明らかになった.
- 生体細胞による封じ込めは,飽和しない第一次流動性 (k=0.465/hr) に従った.
- 結合はヘパリンとトロンビンとは独立しており,結合分子は介質に放出されませんでした.
結論:
- 線維芽細胞は,活性組織プラズミノゲン活性化剤 (tPA) の表面受容体を持っています.
- 結合後,tPAは内蔵され,その後,線維芽細胞によって分解されます.
- このフィブロブラスト媒介のtPA結合メカニズムは,プロテアゼネキシン媒介の結合とは異なる.
関連する概念動画
Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.


